{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:59:20Z","timestamp":1785257960864,"version":"3.55.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2026,7,21]]},"abstract":"<jats:p xml:lang=\"en\">Restricting sodium intake has been identified as one of the most cost\u2010effective measures to improve public health. The substantial improvements in blood pressure and cardiovascular outcomes observed after dietary sodium restriction in clinical trials and observational studies provide evidence\u2010based support for national strategies that recommend limits on daily sodium consumption. Although dietary sources of sodium account for most of an individual's intake, the sodium content of pharmaceutical products can also contribute to excess sodium intake, thereby increasing cardiovascular risk. Sodium is included in oral medications as an active ingredient (or as a cation for an active ingredient) or to enhance solubility. The sodium content of certain medications can exceed the daily recommended maximal sodium intake if higher doses are administered. In this contemporary review, we describe the basis of cardiovascular risk with increased sodium intake as it pertains to the clinical relevance of medications with a high\u2010sodium content that are associated with increases in blood pressure, development of hypertension, and adverse cardiovascular outcomes. Improvements in approaches to sodium content labeling and prescriber education are warranted to ensure that patients receive appropriate therapeutic options.<\/jats:p>","DOI":"10.1161\/jaha.126.050798","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:56:10Z","timestamp":1784285770000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium\u2010Containing Pharmaceutical Products as Contributors to Cardiovascular Risk"],"prefix":"10.1161","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-8491","authenticated-orcid":false,"given":"William B.","family":"White","sequence":"first","affiliation":[{"name":"University of Connecticut School of Medicine","place":["Farmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-9168","authenticated-orcid":false,"given":"Richard J.","family":"Kovacs","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine","place":["Indianapolis, USA"]},{"name":"American College of Cardiology","place":["Washington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2025.100409"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1617644"},{"key":"e_1_3_1_4_2","unstructured":"US Department of Agriculture and US Department of Health and Human Services . Dietary guidelines for Americans 2020\u20132025. 2020. Accessed October 2025. https:\/\/www.dietaryguidelines.gov\/sites\/default\/files\/2020\u201012\/Dietary_Guidelines_for_Americans_2020\u20102025.pdf."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030585"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024446"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530440070039"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.2.643S"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001575"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39147.604896.55"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006032"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440101"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmab008"},{"key":"e_1_3_1_14_2","unstructured":"FDA . Voluntary sodium reduction goals: target mean and upper bound concentrations for sodium in commercially processed packaged and prepared foods (Edition 2): guidance for industry. 2024. Accessed October 2025. https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/draft\u2010guidance\u2010industry\u2010voluntary\u2010sodium\u2010reduction\u2010goals\u2010edition\u20102."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000249"},{"key":"e_1_3_1_16_2","unstructured":"World Health Organization . WHO Global Report on Sodium Intake reduction. 2023. Accessed October 2025. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/296605a9\u2010820a\u201041bc\u20108f28\u2010bf4b1367d530\/content."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12726"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6644.319"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31376-X"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1326"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480090061028"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440270105009"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1325"},{"key":"e_1_3_1_24_2","unstructured":"World Health Organization . Sodium reduction. 2025. Accessed October 2025. https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/sodium\u2010reduction."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd010166.pub2"},{"key":"e_1_3_1_26_2","unstructured":"National Academies Science E Medicine (NASEM) . Sodium and potassium dietary reference intake values updated in new report: introduces new category for sodium based on chronic disease risk reduction. 2019. Accessed October 2025. https:\/\/www.nationalacademies.org\/news\/2019\/03\/sodium\u2010and\u2010potassium\u2010dietary\u2010reference\u2010intake\u2010values\u2010updated\u2010in\u2010new\u2010report."},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2019.5778"},{"key":"e_1_3_1_28_2","unstructured":"NHS . Salt in your diet. 2023. Accessed October 2025. https:\/\/www.nhs.uk\/live\u2010well\/eat\u2010well\/food\u2010types\/salt\u2010in\u2010your\u2010diet\/."},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.17886\/RKI-GBE-2016-041"},{"key":"e_1_3_1_30_2","unstructured":"World Action on Salt Sugar and Health . Spain. 2013. Accessed October 2025. https:\/\/www.worldactiononsalt.com\/worldaction\/europe\/spain\/#:~:text=According%20to%20a%202013%20report%20from%20the to%20less%20than%205%20grams%20per%20day."},{"key":"e_1_3_1_31_2","unstructured":"Public Health England . National diet and nutrition survey. Assessment of salt intake from urinary sodium in adults (aged 19 to 64\u2009years) in England 2018 to 2019. 2020. Accessed October 2025. https:\/\/assets.publishing.service.gov.uk\/media\/5e7cd9cdd3bf7f133ed1b6a1\/Report_England_Sodium_Survey_2018\u2010to\u20102019__3_.pdf."},{"key":"e_1_3_1_32_2","unstructured":"US Department of Agriculture and US Department of Health and Human Services . The scientific foundation for the dietary guidelines for Americans 2025\u20132030. 2026. Accessed February 2026. https:\/\/cdn.realfood.gov\/Scientific%20Report_1.8.26.pdf."},{"key":"e_1_3_1_33_2","unstructured":"Food and Drug Administration . Voluntary sodium reduction goals: target mean and upper bound concentrations for sodium in commercially processed packaged and prepared foods: guidance for industry. 2021. Accessed February 2026. https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/guidance\u2010industry\u2010voluntary\u2010sodium\u2010reduction\u2010goals."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006021"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13326"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112630"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.11.003"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01844-y"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(94)00060-7"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.2.652S"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050371"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-022-01182-9"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.07.745"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100980"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.606"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907355"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4044"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16649"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311889"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.574"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.3945\/an.113.005033"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000015"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(92)90062-U"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109794"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1993.tb01496.x"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001307"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13117"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.055"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-021-00909-4"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-021-00383-z"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt143"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.23382"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03333-9"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.23651"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.3.422"},{"key":"e_1_3_1_66_2","unstructured":"European Medicines Agency . Questions and answers on sodium in the context of the revision of the guideline on \u2018Excipients in the label and package leaflet of medicinal products for human use\u2019 (CPMP\/463\/00 Rev.1). 2015. Accessed October 2025. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory\u2010procedural\u2010guideline\/draft\u2010questions\u2010and\u2010answers\u2010sodium\u2010context\u2010revision\u2010guideline\u2010excipients\u2010label\u2010and\u2010package\u2010leaflet\u2010medicinal\u2010products\u2010human\u2010use_en.pdf."},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043566"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6954"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2024.05.029"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-076302"},{"key":"e_1_3_1_71_2","unstructured":"FDA . Quantitative labeling of sodium potassium and phosphorus for human over\u2010the\u2010counter and prescription drug products. 2022. Accessed October 2025. https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/quantitative\u2010labeling\u2010sodium\u2010potassium\u2010and\u2010phosphorus\u2010human\u2010over\u2010counter\u2010and\u2010prescription\u2010drug."},{"key":"e_1_3_1_72_2","unstructured":"National Archives and Records Administration . Code of Federal Regulations. Title 21. Chapter I. 2026. Accessed February 2026. https:\/\/www.ecfr.gov\/current\/title\u201021\/chapter\u2010I."},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180634"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1701"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001733"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac054"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1505574"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad161"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.25730"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac059"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad535"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad673"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.2.708S"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.20545"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/48.6.1463"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab888"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.126.050798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:08:05Z","timestamp":1785254885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.126.050798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":85,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7,21]]}},"alternative-id":["10.1161\/JAHA.126.050798"],"URL":"https:\/\/doi.org\/10.1161\/jaha.126.050798","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2026-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e050798"}}